<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/cronus-pharma-fda-approved-generic-robenacoxib-injection-veterinary</loc>
    <lastmod>2026-08-27T21:55:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Cronus Pharma Wins FDA Nod for Generic Robenacoxib Injection</news:title>
      <news:keywords>Cronus</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/e1816447-701a-4a89-b876-ba65c6313cbe.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/propanc-biopharma-prp-preclinical-pdac-tumor-growth-inhibition</loc>
    <lastmod>2026-08-27T22:07:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Propanc Reports Over 90% Tumor Inhibition for PRP</news:title>
      <news:keywords>Propanc</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/a2d48b7a-a99d-4f3e-990b-8af21728309b.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/verrica-pharmaceuticals-cove-2-enrollment-complete-ycanth-common-warts-phase-3</loc>
    <lastmod>2026-08-27T21:50:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Verrica Completes COVE-2 Enrollment for YCANTH</news:title>
      <news:keywords>Verrica</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/722fa2d3-9375-4ff9-b323-cbae2fd73544.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbott-gains-ce-mark-amulet-360-laa-occluder-atrial-fibrillation</loc>
    <lastmod>2026-08-27T21:54:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Abbott Wins CE Mark for Amulet 360 LAA Occluder</news:title>
      <news:keywords>Abbott</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cormica-compounding-enforcement-roadmap-503a-503b-inspection-deficiencies</loc>
    <lastmod>2026-08-27T22:01:06+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Cormica Publishes FDA Compounding Enforcement Roadmap</news:title>
      <news:keywords>Cormica</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/08/pharmaceutical-cleanroom-image.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sanofi-fda-updated-approval-tenivac-td-vaccine-august-2026</loc>
    <lastmod>2026-08-27T21:57:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Sanofi Gains Updated FDA Approval for TENIVAC Vaccine</news:title>
      <news:keywords>Sanofi</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/24fe4e02-fbb6-4f64-b1a2-5f1095b4d548.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/moleculin-miracle-trial-phase-2-3-aml-enrollment-milestone</loc>
    <lastmod>2026-08-27T22:05:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Moleculin Hits Enrollment Milestone in Relapsed AML Trial</news:title>
      <news:keywords>Moleculin</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d83a300c-4c69-4e05-ac31-a2bdc478f10e/ac46bc10-b3d5-4fa0-8a7a-a4f8cc0ed0d7.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/nicox-secures-april-2027-pdufa-date-ncx-470-glaucoma-nda</loc>
    <lastmod>2026-08-27T14:12:46+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Nicox Secures April 2027 PDUFA Date for NCX 470 Glaucoma Drug NDA</news:title>
      <news:keywords>Nicox</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/89f67468-876a-4ab4-acdc-7d3679a793db/8b7e0483-56a0-414c-b549-cf109f43c89c.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbvie-ema-submission-risankizumab-subcutaneous-induction-crohns-disease</loc>
    <lastmod>2026-08-27T14:09:54+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>AbbVie Submit EMA Application for Risankizumab in Crohn’s Disease</news:title>
      <news:keywords>AbbVie</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/89f67468-876a-4ab4-acdc-7d3679a793db/bb884e2e-78b5-412c-a5bc-5a7d975c3898.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/revolution-medicines-fda-approval-daraxonrasib-metastatic-pancreatic-adenocarcinoma</loc>
    <lastmod>2026-08-27T14:09:58+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-27T00:00:00+05:30</news:publication_date>
      <news:title>Revolution Medicines Wins FDA Approval for Daraxonrasib in mPDAC</news:title>
      <news:keywords>Revolution Medicines</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e05d6b50-0a18-4510-b500-c4b2cf08f0ac/aed6f2ac-fbf1-459e-b9df-9f130270dda1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/priovant-therapeutics-valor-trial-brepocitinib-dermatomyositis-skin-outcomes</loc>
    <lastmod>2026-08-26T22:05:53+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Priovant Publishes Phase 3 Brepocitinib Skin Outcomes</news:title>
      <news:keywords>Priovant</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/73d7ff2c-b2ad-4820-aad5-c53bd1e0d041/ccb90d18-fbe0-46b5-857f-be599c7da8e6.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/revolution-medicines-fda-approval-daraxonrasib-metastatic-pancreatic-adenocarcinoma</loc>
    <lastmod>2026-08-26T22:04:39+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Revolution Medicines Wins FDA Approval for Daraxonrasib</news:title>
      <news:keywords>Revolution</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/73d7ff2c-b2ad-4820-aad5-c53bd1e0d041/13520b3a-ddfc-455a-8037-3d86427980f9.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/baxter-recalls-sodium-chloride-injection-fiberglass-particulate-contamination-2026</loc>
    <lastmod>2026-08-26T22:02:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Baxter Recalls Two Sodium Chloride Lots Over Fiberglass</news:title>
      <news:keywords>Baxter</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/73d7ff2c-b2ad-4820-aad5-c53bd1e0d041/76148d95-c103-4dae-bd59-d0f874f76f83.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/aurigene-signs-long-term-manufacturing-deal-20-plus-drug-products-global-markets</loc>
    <lastmod>2026-08-26T13:47:18+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Aurigene Signs Long-Term Deal Covering 20+ Drug Products Globally</news:title>
      <news:keywords>Aurigene</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a57601d2-be80-46af-bc7d-c6419a66bd0c/4e216049-0fb9-4ddd-a0d7-b3eadcb21bdb.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cipla-pithampur-facility-seven-observation-form-483-usfda-follow-up-inspection</loc>
    <lastmod>2026-08-26T13:52:14+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Cipla Pithampur Facility Gets 7-Observation Form 483 From USFDA</news:title>
      <news:keywords>Cipla</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a57601d2-be80-46af-bc7d-c6419a66bd0c/0f9b4b57-ac67-4737-aa3d-7f2e7502eec1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ascendis-pharma-week-104-approch-trial-yuviwel-isds-2026</loc>
    <lastmod>2026-08-26T13:47:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Ascendis Presents Week 104 Approach Trial Data for YUVIWEL</news:title>
      <news:keywords>Ascendis</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/4d0b87ab-9e96-4b29-8ac0-ccfa3f05e171.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-approves-tivicay-pd-oral-suspension-hiv-neonates</loc>
    <lastmod>2026-08-26T13:52:15+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>FDA Approves Tivicay PD for HIV Treatment in Newborns</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/1d3e780c-8260-4a72-99b5-d0492b1e6b93.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-accelerated-approval-tracker-benznidazole-hepcludex-pmr-deadlines</loc>
    <lastmod>2026-08-26T13:52:15+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>FDA Tracker Flags Benznidazole PMR, Hepcludex Faces 2034 Deadline</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/9368ee86-7984-457c-a13f-2e69cda8c3e0.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-wap-sensual-enhancement-undeclared-api-adulteration-2026</loc>
    <lastmod>2026-08-26T13:47:09+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>FDA Confirm WAP Sensual Enhancement Has Four Undeclared Drugs Key</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/9b92c49f-cdd7-47ce-9a4f-bf5e054f1615.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/baxter-recalls-70-percent-dextrose-injection-stainless-steel-particulate-contamination</loc>
    <lastmod>2026-08-26T13:47:06+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-26T00:00:00+05:30</news:publication_date>
      <news:title>Baxter Recalls Dextrose Injection Lot Over Steel Contamination</news:title>
      <news:keywords>Baxter</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/35497d58-26dd-4886-8738-41454359bee3/7fd91d3a-3e7c-47d0-be71-0dba57d0e57b.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/unichem-laboratories-appoints-pabitra-kumar-bhattacharya-md-ceo</loc>
    <lastmod>2026-08-25T22:33:44+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Unichem Appoints Pabitra Kumar Bhattacharya as MD and CEO</news:title>
      <news:keywords>Unichem</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e4a583c-72d1-432f-a367-b2d0c3e71f2f/08719b82-7c14-47a8-9843-e0d76a338ed3.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/olympia-pharmaceuticals-launches-polidocanol-2-percent-injectable-cosmetic-vein-treatment</loc>
    <lastmod>2026-08-25T22:10:39+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Olympia Launches Polidocanol Injection Across 49 States</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fa6fa982-051a-4c38-84c9-e4b58a808720/07492625-4272-42ff-bbaf-c6d48e79036e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-medwatch-thyroid-tablet-recall-potency-control-solid-oral-dose</loc>
    <lastmod>2026-08-25T22:25:36+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA MedWatch Framework Flags Thyroid Tablet Recall Amid Potency Concerns</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fa6fa982-051a-4c38-84c9-e4b58a808720/7f14d382-d6b3-4076-a36b-d3dd9f1da474.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-approves-zanidatamab-tislelizumab-her2-positive-gastric-esophageal-adenocarcinoma</loc>
    <lastmod>2026-08-25T22:29:17+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Approves Zanidatamab and Tislelizumab for HER2-Positive GI Cancers</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fa6fa982-051a-4c38-84c9-e4b58a808720/1d3a34d5-5b2e-4975-a047-20f149112c51.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-confirms-undisclosed-dexamethasone-qu-feng-huo-lou-dan</loc>
    <lastmod>2026-08-25T22:01:55+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Finds Undeclared Dexamethasone in Pain-Relief Product</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fa6fa982-051a-4c38-84c9-e4b58a808720/6f7ef20f-5c84-4d6a-9adf-6ce63948ffa5.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/regenxbio-second-clinical-hold-rgx-121-spine-mri-findings</loc>
    <lastmod>2026-08-25T22:35:56+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>REGENXBIO Faces Second FDA Clinical Hold on RGX-121</news:title>
      <news:keywords>REGENXBIO</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fa6fa982-051a-4c38-84c9-e4b58a808720/d873c379-43ef-4aab-b30a-edde3264dd6c.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/janssen-fda-approval-nipocalimab-aahu-waiha-first-drug</loc>
    <lastmod>2026-08-25T22:32:30+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Janssen Wins FDA Approval for Nipocalimab as First Warm AIHA Drug</news:title>
      <news:keywords>Janssen</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fa6fa982-051a-4c38-84c9-e4b58a808720/1c225320-a851-40d8-ad39-3449a180e20c.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-bayesian-methodology-guidance-webinar-october-2026</loc>
    <lastmod>2026-08-25T11:38:27+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Schedules Bayesian Guidance Webinar For Regulatory Teams</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/32d73393-66d6-4474-8ff0-48f63b576e0e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-dscsa-waiver-exception-exemption-small-business-dispenser-2026</loc>
    <lastmod>2026-08-25T18:34:33+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Updates DSCSA Waiver Framework With Small Business Exemption</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/a33e2305-baf7-44cb-9887-33fb77e5e669.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-drug-supply-chain-security-framework-dscsa-compliance</loc>
    <lastmod>2026-08-25T18:34:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Reinforces Multi-Layer Drug Supply Chain Security Framework</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/6c47a5e4-d08a-40e1-86f7-b8d500af78e1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/vitruvias-therapeutics-recalls-thyroid-tablets-usp-30mg-superpotency-lot-504950</loc>
    <lastmod>2026-08-25T12:15:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Vitruvias Recalls Thyroid Tablets 30 mg Lot Over Superpotency</news:title>
      <news:keywords>Vitruvias</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/c2e6541f-198f-40df-9a9d-b4481c54f9dc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/capricor-therapeutics-deramiocel-bla-review-extension-november-2026</loc>
    <lastmod>2026-08-25T18:34:37+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Capricor's Deramiocel Gets November 2026 FDA Review Date</news:title>
      <news:keywords>Capricor Therapeutics</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/cbaf4cb0-7164-4486-8444-f3881c5a67e6.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-ectd-40-esg-cloud-modernization-pdufa-vii</loc>
    <lastmod>2026-08-25T18:34:44+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Advances eCTD 4.0 and ESG Cloud Modernization Under PDUFA VII</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/b227f490-a4a5-45e6-90ef-ddb2f1b0c218.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-rdea-meeting-package-requirements-rare-disease-novel-endpoints</loc>
    <lastmod>2026-08-25T12:18:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Sets RDEA Meeting Requirements for Rare Disease Endpoints</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/f1b2ea3b-ae32-4c1b-95ad-4fc7a1e60733.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-updates-counterfeit-ozempic-warning-glp1-supply-chain-risks-2025</loc>
    <lastmod>2026-08-25T12:17:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Updates Ozempic Counterfeit Warning Amid GLP-1 Risks</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/b0f48762-683b-448d-ba8d-8d02ba57a78a.png</image:loc>
    </image:image>
  </url>
</urlset>